FdaApplication

ANDA 062055

Back to search

Identifiers

Properties

PropertyValue
applicant_nameANI PHARMACEUTICALS INC
application_typeANDA
approval_date2018-11-02

Products (3)

ProductActive ingredientStrengthDosage form
ERYTHROMYCIN ETHYLSUCCINATEERYTHROMYCIN ETHYLSUCCINATEEQ 200MG BASE/5MLGRANULE;ORAL
ERYTHROMYCIN ETHYLSUCCINATEERYTHROMYCIN ETHYLSUCCINATEEQ 400MG BASE/5MLGRANULE;ORAL
ERYTHROMYCIN ETHYLSUCCINATEERYTHROMYCIN ETHYLSUCCINATEEQ 200MG BASE/5MLGRANULE;ORAL

3 products